1. Home
  2. PRTC vs BBW Comparison

PRTC vs BBW Comparison

Compare PRTC & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • BBW
  • Stock Information
  • Founded
  • PRTC 2015
  • BBW 1997
  • Country
  • PRTC United States
  • BBW United States
  • Employees
  • PRTC N/A
  • BBW N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • BBW Recreational Games/Products/Toys
  • Sector
  • PRTC Health Care
  • BBW Consumer Discretionary
  • Exchange
  • PRTC Nasdaq
  • BBW Nasdaq
  • Market Cap
  • PRTC 413.5M
  • BBW 464.1M
  • IPO Year
  • PRTC N/A
  • BBW 2004
  • Fundamental
  • Price
  • PRTC $19.07
  • BBW $51.34
  • Analyst Decision
  • PRTC Buy
  • BBW Strong Buy
  • Analyst Count
  • PRTC 1
  • BBW 4
  • Target Price
  • PRTC $45.00
  • BBW $54.75
  • AVG Volume (30 Days)
  • PRTC 3.4K
  • BBW 213.1K
  • Earning Date
  • PRTC 08-27-2025
  • BBW 08-28-2025
  • Dividend Yield
  • PRTC N/A
  • BBW 1.71%
  • EPS Growth
  • PRTC N/A
  • BBW 19.03
  • EPS
  • PRTC 0.21
  • BBW 4.15
  • Revenue
  • PRTC $4,828,000.00
  • BBW $510,069,000.00
  • Revenue This Year
  • PRTC $35.98
  • BBW $6.10
  • Revenue Next Year
  • PRTC $115.38
  • BBW $3.90
  • P/E Ratio
  • PRTC $8.64
  • BBW $12.37
  • Revenue Growth
  • PRTC 44.98
  • BBW 6.09
  • 52 Week Low
  • PRTC $13.30
  • BBW $23.63
  • 52 Week High
  • PRTC $25.00
  • BBW $55.57
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 57.26
  • BBW 50.14
  • Support Level
  • PRTC $18.16
  • BBW $51.56
  • Resistance Level
  • PRTC $19.60
  • BBW $55.42
  • Average True Range (ATR)
  • PRTC 0.43
  • BBW 1.78
  • MACD
  • PRTC 0.10
  • BBW -0.26
  • Stochastic Oscillator
  • PRTC 69.77
  • BBW 40.07

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

Share on Social Networks: